“Therapeutic innovation in B-cell malignancies: Present and future”, Gilead Sciences Hellas, 26 September 2015
The Institute of Applied Biosciences and Gilead Sciences Hellas organize an educational event titled:
“Therapeutic innovation in B-cell malignancies: Present and future”
The main objective of this event is to foster appreciation of disease pathophysiology and rational therapy towards the direction of personalized medicine by scientists involved in the diagnosis and management of patients with CLL and lymphomas, with a focus on practicing physicians.
The event will take place in the Amphitheater «Vergina», Central Administration Building, CERTH
6th Km Charilaou-Thermi Road, Thessaloniki, Greece
on Saturday, September 26th, 2015, 09:00am to 18.00pm.
For more information please contact Mrs. Stavroula Smerla
e-mail: email@example.com, tel: +30 2311 257526